FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: While the FDA's decision is national, the approval of a new mRNA flu vaccine could influence vaccine availability and public health initiatives through agencies like the Wisconsin Department of Health Services and local health departments across the state.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.